Cargando…

An immunotherapy response prediction model derived from proliferative CD4(+) T cells and antigen-presenting monocytes in ccRCC

Most patients with clear cell renal cell carcinoma (ccRCC) have an impaired response to immune checkpoint blockade (ICB) therapy. Few biomarkers can predict responsiveness, and there is insufficient evidence to extend them to ccRCC clinical use. To explore subtypes and signatures of immunocytes with...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Kun, Gao, Lianchong, Hao, Jie, Zou, Xin, Hu, Xiaoyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452905/
https://www.ncbi.nlm.nih.gov/pubmed/36091022
http://dx.doi.org/10.3389/fimmu.2022.972227

Ejemplares similares